All Videos

Should you close your practice? Retire? Will the mask mandates shift a focus to eye procedures? Is money an issue? Dr. Joe Niamtu shares his perspective.

Cath O'Niell, chief scientific officer at SkinBioTherapeutics and professor of translational dermatology at the University of Manchester, discusses her recent research on developing probiotics to treat psoriasis and other inflammatory skin diseases.

Hema Sundaram, MA, MD, FAAD, highlights an exciting new technology that may change the future of aesthetic therapeutics.

In this video, Hema Sundaram, MA, MD, FAAD, highlights important safety considerations to keep in mind regarding laser-assisted drug delivery.

Botulinum toxin may help address erythema and flushing in patients with refractory rosacea, according to data presented by Hema Sundaram, MA, MD, FAAD, at the AAD Virtual Meeting Experience (VMX) on June 12.

In this video, Hema Sundaram, MA, MD, FAAD, shares pearls on fat grafting from her presentation at the AAD Virtual Meeting Experience (VMX) in June.

Hema Sundaram, MA, MD, FAAD, breaks down how botulinum toxin can be used to treat scars, a topic she discussed during her presentation at the AAD Virtual Meeting Experience (VMX) on June 12.

Dr. Greg Chernoff discusses two recently published studies that examine the benefits of nitric oxide for anti-aging and acne.

Dr. Jeffrey Dover shares what we’ve learned about COVID-19 since reopening the aesthetic practice.

In the final installment of our conversation with Adam Friedman, M.D., FAAD, he details what dermatologists should keep in mind when posting to social media.

Marketing expert Sam Peek discusses the current landscape, including opportunities afforded the aesthetic practice by the pandemic.

In part three of our video interview with Adam Friedman, M.D., FAAD, he discusses some of the benefits and pitfalls of colleague-to-colleague engagement on social media.

In part two of our conversation with Adam Friedman, M.D., FAAD, he offers insight on which patients look for a dermatologist on social media and what types of content produce the most engagement online.

In part one of our interview with Adam Friedman, M.D., FAAD, he discusses the data from a recent survey study that examines the influence of dermatologists' social media use on attracting new patients.

From post-procedure laser to surgical facelift recovery, Dr. Joe Niamtu III offers insight and advice for patient healing challenges in and around the mid- and lower face from wearing a face mask.

In part two of our interview with Iltefat H. Hamzavi, M.D., he delves into the data from a recent article investigating the use ultraviolet germicidal irradiation (UVGI) as a method to disinfect N95 respirators for reuse during the COVID-19 pandemic.

In part one of our video interview with Iltefat H. Hamzavi, M.D., he discusses how ultraviolet germicidal irradiation is used in dermatology and how it can be used to disinfect N95 respirators to facilitate reuse during the COVID-19 pandemic.

Dr. Joe Niamtu offers pearls and pitfalls of the virtual cosmetic surgery consultation in telemedicine.

Dermatology patients are hungry for information that will ensure their safety during the COVID-19 pandemic, notes Vivian Shi, M.D. In this video, she discusses how to address patients' varying concerns in this uncertain time.

In the webinar, "Forging an Industry-Practice Partnership During COVID-19," Dr. Waldman and a panel of key executives discuss how the industry is adapting, the means by which we can support each other and what the future holds.

In the final installment of our interview with Amy Paller, M.D., she explains the similarities and differences between Kawasaki disease and the novel condition, multisystem inflammatory syndrome in children (MIS-C).

Part three of our interview with Amy Paller, M.D., focuses on the emergence of a multisystem inflammatory syndrome in children (MIS-C), what we know about this novel condition and its relationship to COVID-19.

In light of the ongoing pandemic, Vivian Shi, M.D., discusses potential risks dermatologists will want to keep in mind when evaluating patients currently taking immunomodulator or immunosuppressant drugs.

In part two of our interview with Amy Paller, M.D., she describes how she is staying informed about the latest COVID-19 research as it relates to the field, and shares some resources other dermatologists may find helpful during this crisis.

Amy Paller, M.D., discusses the pernio-like lesions associated with possible COVID-19 infection in younger individuals.

In this 1-hour webinar, Dr. Randolph Waldman and a panel of experts drill down into the legal concerns physicians are facing that are unique to the #COVID19 time period, including liability risk, consents, and protection strategies.

Jonathan Silverberg, M.D., Ph.D., MPH, discusses criteria to keep in mind when evaluating a patient with possible atopic dermatitis.

This week, we spoke with Mark Lebwohl, M.D., about his recent article featured in the Journal of the American Academy of Dermatology regarding biologic use in dermatology patients during the COVID-19 pandemic.

Dr. L. Mike Nayak recalls his decision to go virtual for his Medspa Mastery course. Adding #NoFilter to the name, he says that he wants to take the best part of going to conferences — small group and one-on-one discussions with colleagues — and bring it to the computer screen.